Literature DB >> 33388764

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies.

Héctor Bueno1,2,3,4, Brenda Moura5,6, Patrizio Lancellotti7,8, Johann Bauersachs9.   

Abstract

Entities:  

Keywords:  Activators of soluble guanylate cyclase; Angiotensin receptor–neprilysin inhibitors; Biomarkers; Cardiac myosin activators and inhibitors; Clinical practice; Epidemiology; Heart failure; Imaging; Pharmacotherapy; Randomized control trials; SGLT-2 inhibitor; Telemedicine

Year:  2021        PMID： 33388764     DOI： 10.1093/eurheartj/ehaa1061

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Dual Specific Phosphatase 7 Exacerbates Dilated Cardiomyopathy, Heart Failure, and Cardiac Death by Inactivating the ERK1/2 Signaling Pathway.

Authors:  Jing Liu; Yihen Yin; Jing Ni; Peiyu Zhang; Wei-Ming Li; Zheng Liu
Journal:  J Cardiovasc Transl Res       Date:  2022-05-20       Impact factor: 4.132

Review 2.  Translation of New and Emerging Therapies for Genetic Cardiomyopathies.

Authors:  Adam S Helms; Andrea D Thompson; Sharlene M Day
Journal:  JACC Basic Transl Sci       Date:  2021-12-01

Review 3.  Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions.

Authors:  Mengxi Yang; Di Sun; Yu Wang; Mengwen Yan; Jingang Zheng; Jingyi Ren
Journal:  Front Cardiovasc Med       Date:  2022-02-07

Review 4.  Designer Functional Nanomedicine for Myocardial Repair by Regulating the Inflammatory Microenvironment.

Authors:  Chunping Liu; Zhijin Fan; Dongyue He; Huiqi Chen; Shihui Zhang; Sien Guo; Bojun Zheng; Huan Cen; Yunxuan Zhao; Hongxing Liu; Lei Wang
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

5.  Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation.

Authors:  Franziska E Uhl; Lotte Vanherle; Anja Meissner
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.